Pay in 4 interest-free payments of $26.77 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Treatment of AML cell lines (MV4-11 and THP-1) and primary blasts with HLCL-61 also results in a decrease of cell viability
Roscovitine displays high efficiency and high selectivity towards some cyclin-dependent kinases with IC50 of 0
Formula: C63H91CoN13O14P
shows a stronger scavenging effect of Peroxynitrite than N-acetyl-cysteine on DCDHF oxidation in vitro and in sputum macrophages
1 In clinical trials
Sitafloxacin hydrate Catalog No.:M8991-10 Treatment of AML cell linesSitafloxacin is a new generation, broad spectrum oral fluoroquinolone that is very active against many Gram positive, Gram negative and anaerobic clinical isolates, including strains resistant to other fluoroquinolones, was recently approved in Japan for the treatment of respiratory and urinary tract infections. Sitafloxacin is active against methicillin resistant staphylococci, Streptococcus pneumoniae and other streptococci with reduced